[
  {
    "ts": null,
    "headline": "Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents",
    "summary": "U.S. Health SecretaryRobert Kennedy Jr. named eight members to serve on a key panelof vaccine advisers on Wednesday, including several who haveadvocated against vaccines, after abruptly firing all...",
    "url": "https://finnhub.io/api/news?id=69ca30310667aeebcb7c2ff469b5a86cda1243b0660dae2699096a960ac0f8c7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749661028,
      "headline": "Kennedy replaces fired US CDC panel members, includes anti-vaccine proponents",
      "id": 135194958,
      "image": "",
      "related": "PFE",
      "source": "Finnhub",
      "summary": "U.S. Health SecretaryRobert Kennedy Jr. named eight members to serve on a key panelof vaccine advisers on Wednesday, including several who haveadvocated against vaccines, after abruptly firing all...",
      "url": "https://finnhub.io/api/news?id=69ca30310667aeebcb7c2ff469b5a86cda1243b0660dae2699096a960ac0f8c7"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE)",
    "summary": "Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers, had a meeting with the Trump administration to talk about reducing US drug prices. However, Pfizer’s chief executive, Albert Bourla, mentioned that no commitments have been agreed upon. President Trump ordered drugmakers last […]",
    "url": "https://finnhub.io/api/news?id=936c7bd75963c269c29d86d2b77fa845c3e2ca86bf552abc1fe70147de2af05e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749655632,
      "headline": "Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE)",
      "id": 135198689,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer Inc. (NYSE:PFE) is one of the best wide moat stocks to buy now. On June 9, Pfizer, along with other drug manufacturers, had a meeting with the Trump administration to talk about reducing US drug prices. However, Pfizer’s chief executive, Albert Bourla, mentioned that no commitments have been agreed upon. President Trump ordered drugmakers last […]",
      "url": "https://finnhub.io/api/news?id=936c7bd75963c269c29d86d2b77fa845c3e2ca86bf552abc1fe70147de2af05e"
    }
  },
  {
    "ts": null,
    "headline": "Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel",
    "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, “Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agenci",
    "url": "https://finnhub.io/api/news?id=0fb2c9884a3d968b1b0c30f15e468bdc5f7226238ff1a399f8ca9a402bd38ad7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749651653,
      "headline": "Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel",
      "id": 135184593,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: VACCINE ADVISORY COMMITTEE: In an opinion article published by The Wall Street Journal, Robert F. Kennedy Jr. stated, “Vaccines have become a divisive issue in American politics, but there is one thing all parties can agree on: The U.S. faces a crisis of public trust. Whether toward health agenci",
      "url": "https://finnhub.io/api/news?id=0fb2c9884a3d968b1b0c30f15e468bdc5f7226238ff1a399f8ca9a402bd38ad7"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer says drugmakers met with Trump admin to discuss lowering drug prices",
    "summary": "Pfizer (PFE) and other drugmakers met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Pfizer CEO Albert Bourla said on Monday at the Goldman Sachs Healthcare Conference. Boula said the meetings “were cordial,” but they were not “digging into the substance yet,” adding that “it is just trying to understand high-level ideas and no commitments. So what could be the outcomes of something like that? It could be from nothing to very big.”” Publishe",
    "url": "https://finnhub.io/api/news?id=6ebd7aec5e37dc39453d6f7d587821a5e35552060fb807da1dffb941823c7632",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749649218,
      "headline": "Pfizer says drugmakers met with Trump admin to discuss lowering drug prices",
      "id": 135180179,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Pfizer (PFE) and other drugmakers met with the Trump administration to discuss lowering U.S. drug prices but no commitments have been made, Pfizer CEO Albert Bourla said on Monday at the Goldman Sachs Healthcare Conference. Boula said the meetings “were cordial,” but they were not “digging into the substance yet,” adding that “it is just trying to understand high-level ideas and no commitments. So what could be the outcomes of something like that? It could be from nothing to very big.”” Publishe",
      "url": "https://finnhub.io/api/news?id=6ebd7aec5e37dc39453d6f7d587821a5e35552060fb807da1dffb941823c7632"
    }
  },
  {
    "ts": null,
    "headline": "OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy",
    "summary": "OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy",
    "url": "https://finnhub.io/api/news?id=b0e24d2eef40696ab478bef72b45aad4bc97e8172e5ce9bc2a9c037a1feb84d8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749631854,
      "headline": "OPKO Health: Strong Pipeline Of Drugs, But Not Rushing To Buy",
      "id": 135179318,
      "image": "",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=b0e24d2eef40696ab478bef72b45aad4bc97e8172e5ce9bc2a9c037a1feb84d8"
    }
  }
]